e-learning
resources
Stockholm 2002
Sunday 15.09.2002
Interstitial lung disorders: markers of disease activity and severity
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
BAL cell counts in the diagnosis of lung diseases: is there a gain in information?
L. Welker, R. A. Jörres, H. Magnussen (Grosshansdorf, Germany)
Source:
Annual Congress 2002 - Interstitial lung disorders: markers of disease activity and severity
Session:
Interstitial lung disorders: markers of disease activity and severity
Session type:
Oral Presentation
Number:
1119
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Welker, R. A. Jörres, H. Magnussen (Grosshansdorf, Germany). BAL cell counts in the diagnosis of lung diseases: is there a gain in information?. Eur Respir J 2002; 20: Suppl. 38, 1119
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases
Source: Eur Respir J 2004; 24: 1000-1006
Year: 2004
Diagnostic value of total cell count in bronchoalveolar lavage fluid from patients with interstitial lung diseases
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009
Concordance analysis of cells present in bronchoalveolar lavage in patients with interstitial lung diseases by type of readings and pulmonary location
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Immune alveolitis profile in bronchoalveolar lavage of infiltrative lung diseases: not just counting matters.
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Bronchoalveolar lavage: did it fulfill its promises?
Source: Annual Congress 2005 - PG6 - New and old methodologies to assess pathobiological markers in the lung and airways: from research into clinical practice
Year: 2005
Bronchoalveolar lavage differential cell count on assessment of patients with pulmonary fibrosis
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
Red blood cell distribution width in patients with chronic obstructive lung disease:how is changed in exacerbation?
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017
How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Role of BALF in differential diagnosis of smoking related interstitial lung diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 828s
Year: 2006
Are there potential characteristical markers in bronquial fluid for diagnosis of small cell lung cancer (SCLC)?
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Budesoinde/formoterol: does eosinophil count cause different outcomes?
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019
Mechanisms of impaired immune surveillance in lower airways of smokers. Data from bronchoalveolar lavage (BAL) harvested in selected interstitial lung diseases (ILDs) and control group
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
BAL protein profiles specific of different interstitial lung diseases
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012
The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases
Source: Eur Respir Mon; 2009: 46: 36–46
Year: 2009
Markers of activity in clinically recovered human leukocyte antigen-DR17-positive sarcoidosis patients
Source: Eur Respir J 2003; 21: 52-57
Year: 2003
Peripheral lung lesions: what are the options for obtaining a tissue diagnosis?
Source: International Congress 2014 – PG10 Interventional pulmonology
Year: 2014
Diagnostic value of cryobiopsy in patients with interstitial lung diseases integrating bronchoalveolar lavage, radiologic and clinical data
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
Does surgical lung biopsy change the diagnosis and treatment in interstitial lung diseases?
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010
Predictive variables to obtain a bronchoalveolar lavage of adequate quality in patients with interstitial lung diseases
Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease
Year: 2019
The diagnostic value of bronchoalvolar lavage (BAL) in the diagnosis of peripheral lung cancer (PLC)
Source: Eur Respir J 2003; 22: Suppl. 45, 253s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept